Sign-up   Forgot your password?
Home Page  Türkçe  Contact  

       [ ]


Feb 1, 2011

Phase III trial failures..

The therapeutic areas in which the largest proportions of these failures occurred were: cancer (28%); nervous system, which includes neurodegeneration (18%); alimentary and/or metabolism, which includes diabetes and obesity (13%); and anti-infectives (13%).

For full report go to: Nature Reviews

« Back

Clinical Research Association © 2006-2007 PLEKSUS